Immune Pharmaceuticals

Immune Pharmaceuticals says Tony Fiorino resigned as President

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
  • Reports a bankruptcy or receivership (1.03)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

Get an email when Immune Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.